A Phase 1 Study to Assess Absolute Bioavailability of TAK-994 and to Characterize Mass Balance, Pharmacokinetics, Absorption, Metabolism, and Excretion of [14C]TAK-994 in Male Healthy Subjects
Latest Information Update: 02 Nov 2021
At a glance
Most Recent Events
- 28 Jun 2021 Status changed from recruiting to completed.
- 24 May 2021 Planned End Date changed from 30 May 2021 to 20 Jun 2021.
- 24 May 2021 Planned primary completion date changed from 28 May 2021 to 20 Jun 2021.